Search research articles
Contact Us
Filters
Showing results (21-30 of 64) with videos related to
Page
of 7
Sort By:
Biomolecules
|
October 27, 2022
The Epigenetic Dimension of Protein Structure Is an Intrinsic Weakness of the AlphaFold Program
Fodil Azzaz, Nouara Yahi, Henri Chahinian, et al.
Expert Reviews in Molecular Medicine
|
February 28, 2004
Lipid rafts: structure, function and role in HIV, Alzheimer's and prion diseases
Jacques Fantini, Nicolas Garmy, Radhia Mahfoud, et al.
The Journal of Infection
|
June 5, 2021
Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks
Jacques Fantini, Nouara Yahi, Fodil Azzaz, et al.
AIDS (London, England)
|
October 23, 2003
Resistance of HIV-1 to multiple antiretroviral drugs in France: a 6-year survey (1997-2002) based on an analysis of over 7000 genotypes
Catherine Tamalet, Jacques Fantini, Christian Tourres, et al.
Life (Basel, Switzerland)
|
January 28, 2026
Serotonergic Signaling Rewired: A Lipid Raft-Controlled Model of Synaptic Transmission Grounded in the Fundamental Parameters of Biological Systems
Jacques Fantini, Marine Lefebvre, Nouara Yahi, et al.
Biomolecules
|
January 28, 2026
The Enigmatic Conserved Q134-F135-N137 Triad in SARS-CoV-2 Spike Protein: A Conformational Transducer?
Marine Lefebvre, Henri Chahinian, Nouara Yahi, et al.
International Journal of Antimicrobial Agents
|
April 7, 2020
Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
Jacques Fantini, Coralie Di Scala, Henri Chahinian, et al.
International Journal of Molecular Sciences
|
September 28, 2024
Cholesterol-Dependent Serotonin Insertion Controlled by Gangliosides in Model Lipid Membranes
Jacques Fantini, Fodil Azzaz, Ryad Bennaï, et al.
Glycoconjugate Journal
|
July 30, 2021
Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson's disease
Nouara Yahi, Coralie Di Scala, Henri Chahinian, et al.
Scientific Reports
|
March 18, 2025
Preclinical assessment of a ganglioside-targeted therapy for Parkinson's disease with the first-in-class adaptive peptide AmyP53
Jacques Fantini, Fodil Azzaz, Anaïs Aulas, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 64) with videos related to
Sort By:
Page
of 7
Biomolecules
|
October 27, 2022
The Epigenetic Dimension of Protein Structure Is an Intrinsic Weakness of the AlphaFold Program
Fodil Azzaz, Nouara Yahi, Henri Chahinian, et al.
Expert Reviews in Molecular Medicine
|
February 28, 2004
Lipid rafts: structure, function and role in HIV, Alzheimer's and prion diseases
Jacques Fantini, Nicolas Garmy, Radhia Mahfoud, et al.
The Journal of Infection
|
June 5, 2021
Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks
Jacques Fantini, Nouara Yahi, Fodil Azzaz, et al.
AIDS (London, England)
|
October 23, 2003
Resistance of HIV-1 to multiple antiretroviral drugs in France: a 6-year survey (1997-2002) based on an analysis of over 7000 genotypes
Catherine Tamalet, Jacques Fantini, Christian Tourres, et al.
Life (Basel, Switzerland)
|
January 28, 2026
Serotonergic Signaling Rewired: A Lipid Raft-Controlled Model of Synaptic Transmission Grounded in the Fundamental Parameters of Biological Systems
Jacques Fantini, Marine Lefebvre, Nouara Yahi, et al.
Biomolecules
|
January 28, 2026
The Enigmatic Conserved Q134-F135-N137 Triad in SARS-CoV-2 Spike Protein: A Conformational Transducer?
Marine Lefebvre, Henri Chahinian, Nouara Yahi, et al.
International Journal of Antimicrobial Agents
|
April 7, 2020
Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
Jacques Fantini, Coralie Di Scala, Henri Chahinian, et al.
International Journal of Molecular Sciences
|
September 28, 2024
Cholesterol-Dependent Serotonin Insertion Controlled by Gangliosides in Model Lipid Membranes
Jacques Fantini, Fodil Azzaz, Ryad Bennaï, et al.
Glycoconjugate Journal
|
July 30, 2021
Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson's disease
Nouara Yahi, Coralie Di Scala, Henri Chahinian, et al.
Scientific Reports
|
March 18, 2025
Preclinical assessment of a ganglioside-targeted therapy for Parkinson's disease with the first-in-class adaptive peptide AmyP53
Jacques Fantini, Fodil Azzaz, Anaïs Aulas, et al.
Page
of 7